Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Index funds provide low fees and broad market exposure that can simplify retirement investing while aiming for steady growth over time. This guide highlights the why and how.
22,835 articlesSellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Britain’s bond panic currently reshapes how households view cash, debt, and even crypto, as gilt volatility and infla...
Bitcoin mining difficulty drops 7.8% in the latest adjustment, the third weekly decline as miners accelerate an exodu...
Global fertilizer prices surge as conflict with Iran disrupts shipments, tightening U.S. inputs for farmers prepping ...
Indiana Regional MLS is rolling out Navigator by Lundy AI to unify compliance knowledge for its MLS and shareholder a...
The USDA has expanded a Trader Joe's recall to nearly pounds frozen fried rice, now covering close to 10 million poun...
AST SpaceMobile and Rocket Lab fell roughly 4% intraday, then clawed back losses as markets rotated amid a volatile w...
The AI stock story is shifting from last year’s heroes to new winners in 2026. This guide explains why the leadership...
Chewy rode a brighter sales outlook to a rally in its stock, with the company signaling durable demand for pet care d...
As biotech earnings season unfolds, Precigen (PGEN) 2025 earnings take center stage. This guide breaks down what to m...
A former hedge-fund executive warns that investors dangerously complacent about Iran conflict risks as oil volatility...
On a downbeat tech day, software stocks proved resilient as cloud demand and subscription revenue buoyed leaders like...